Assessing Renal Dysfunction Incidence Related to Intravenous Acyclovir Usage
Marwa Said Aljahwari, Mohammad Abobakr Alghazali, Aya Said Alsaidi · 2026
Read Assessing Renal Dysfunction Incidence Related to Intravenous Acyclovir Usage by Marwa Said Aljahwari, Mohammad Abobakr Alghazali, Aya Said Alsaidi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13431250.txt.
Description
Marwa Said Aljahwari, Mohammad Abobakr Alghazali, and Aya Said Alsaidi measured kidney harm tied to a vein-given virus drug at a Muscat hospital in 2026, reviewing care from 2019 through 2023. The drug, acyclovir, can injure kidneys as a known side risk. Patients with prior kidney disease or high base waste levels stayed out of the review.
Ninety-nine patients met the rules. Just over a third grew acute kidney injury after the drug, and near a third of those cases needed a dose cut. All patients got fluids with a slow drip as a guard step. Injury struck patients from outside Oman far more often than local patients. Risk also climbed as the count of other kidney-straining drugs grew. The authors flag both traits for closer watch during treatment.
Catalog record
| CREATOR | Marwa Said Aljahwari, Mohammad Abobakr Alghazali, Aya Said Alsaidi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35259 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |